Two Merck research scientists, Nancy A. Thornberry and Ann E. Weber, Ph.D., will receive the Discoverers Award, the highest honor from the Pharmaceutical Research and Manufacturers of America (PhRMA), during a ceremony tonight at the Liberty Science Center in Jersey City, N.J.
They will be recognized for their leadership in the discovery of JANUVIA®, a once-daily pill that helps patients with type 2 diabetes control glucose in conjunction with diet and exercise. Though women have been part of teams honored with the Discoverers Award in the past, this is the first time in the award’s 24-year history that women alone have won.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/49723/
The second annual “SEND ME 2 VEGAS” sweepstakes begins today, giving one fan a chance to win a 2012 Ford Explorer XLT SUV valued at up to $33,000, two VIP tickets to NASCAR After The Lap™, the opportunity to be featured in an on-air promotional spot on GSN (Game Show Network), a two-night stay at Hard Rock Hotel and Casino Las Vegas and more.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52092-send-me-2-vegas-sweepstakes-2012-ford-explorer-vip-trip-nascar
Megastar MENTOR-MENTEE duo Usher and Justin Bieber perform back to back Sunday night, October 9, on EPIX.
JUSTIN BIEBER NEVER SAY NEVER Director’s Fan Cut
The inspiring true story of the meteoric rise of an average teen to Internet phenomenon and global superstar – the youngest performer to sell out the most famous stage in New York City.
EPIX World Movie Premiere of the version Justin made for his fans. Includes new songs, more performances, hometown friends and fan reactions.
8:00 pm ET
To view Multimedia News Release, go to http://www.multivu.com/mnr/52238-epix-usher-and-bieber-back-2-back-premier-october-9
Bank of the West has seen a rise in mortgage loan applications since April as homeowners seek to take advantage of low interest rates under the government’s Home Affordable Refinance Program (HARP) 2.0.
For consumers wanting to learn more about HARP, Bank of the West has published Eight Essential Harp Tips and introduced an educational video series on HARP loans that can be viewed on YouTube at YouTube.com/Bankofthewest.
“We are anticipating that one out of every five new borrowers will be a homeowner seeking a HARP 2.0 refinance loan this year,” said Karen Mayfield, Bank of the West’s National Sales Manager for the Mortgage Banking Division. “This program is providing real relief for homeowners who are current on their mortgage but have been unable to refinance due to a decline in the value of their home.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54577-bank-of-the-west-mortgage-loan-applications-refinance-harp-2-0
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
There was a time when girls between the ages of three and nine would have been delighted with a doll for Christmas – but now they demand the latest technological gadget.http://www.toyprices.org.uk/leapfrog-leappad-2-pink-explorer-tablet-reviews
Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog® Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they’re giving back to their local communities.
Now through March 15, NovoLog® patients can submit their story and photo online for the chance to be crowned a NovoLog® Community Star. Finalists will be selected by a panel of judges, and each will receive a $5,000 donation to a local diabetes-related organization of their choice. One grand prize winner will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59947-novo-nordisk-first-novolog-community-star-contest-type-2-diabetes-patients
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
http://www.youtube.com/watch?v=ENmwPPMeROo Bill
Price and His Coupled Harmonica. Harmonica, Bill Price, Converting
diatonic harmonicas into lead instruments, playing 2 harmonicas at
once, two harmonicas, harmonica lessons, harmonica songs, harmonica
california dreamin.
